CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −300 | $149.45 | $45K | 1,995,331 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −400 | $150.60 | $60K | 1,994,931 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −700 | $151.73 | $106K | 1,994,231 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −800 | $152.92 | $122K | 1,993,431 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −200 | $153.84 | $31K | 1,993,231 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −600 | $155.66 | $93K | 1,992,631 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,802 | $157.41 | $284K | 1,990,829 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,923 | $158.25 | $304K | 1,988,906 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,200 | $159.57 | $351K | 1,986,706 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −825 | $160.24 | $132K | 1,985,881 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,005 | $162.19 | $163K | 1,984,876 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,223 | $163.02 | $362K | 1,982,653 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −625 | $163.92 | $102K | 1,982,028 |
| 2024-05-22 | AFEYAN NOUBAR Director | Sale 10b5-1 | −97 | $164.67 | $16K | 1,981,931 |
| 2024-05-15 | Hoge Stephen President | Sale 10b5-1 | −15,000 | $127.49 | $1.9M | 1,471,508 |
| 2024-05-15 | AFEYAN NOUBAR Director | Sale 10b5-1 | −4,488 | $125.53 | $563K | 2,007,443 |
| 2024-05-15 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,001 | $126.62 | $253K | 2,005,442 |
| 2024-05-15 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,600 | $127.71 | $332K | 2,002,842 |
| 2024-05-15 | AFEYAN NOUBAR Director | Sale 10b5-1 | −5,711 | $128.75 | $735K | 1,997,131 |
| 2024-05-15 | AFEYAN NOUBAR Director | Sale 10b5-1 | −200 | $129.15 | $26K | 1,996,931 |
Page 30 of 38 · 743 trades